Status:

NOT_YET_RECRUITING

Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter

Lead Sponsor:

Wake Forest University Health Sciences

Conditions:

Intra-Abdominal Hypertension

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to investigate the intra-abdominal pressure utilizing the Accuryn monitoring system during pulsed field ablation procedures in the electrophysiology lab compared to the ty...

Detailed Description

Intra-abdominal pressure (IAP) may play a role in patient outcomes during ablation procedures, as increased IAP could indicate potential adverse events. Such adverse events include aspiration of stoma...

Eligibility Criteria

Inclusion

  • Adult patients receiving pulse field ablation procedures for standard of care treatment of atrial fibrillation and/or atrial flutter.
  • Eligible for Foley catheter placement with no contraindications to Intra-abdominal pressure (IAP) monitoring.

Exclusion

  • Patients under the age of 18 will be excluded.
  • History of intra-abdominal surgery within the past 6 months.
  • Known contraindications to bladder catheterization or catheter ablation; history of prostate issues / Benign prostatic hyperplasia (BPH) or frequent urinary tract infections
  • Pregnant or breastfeeding individuals
  • History of chronic obstructive pulmonary disease (COPD) with home oxygen use

Key Trial Info

Start Date :

March 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 30 2026

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06876896

Start Date

March 1 2026

End Date

July 30 2026

Last Update

December 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wake Forest Health Sciences

Winston-Salem, North Carolina, United States, 27157